Software medication review solution provider in Europe for sale

Company for sale

• Size: Mid-sized
• Revenue: < 3 million EUR
• Location: Europe
• CFIE ITS672

Overview of software medication review solution provider in Europe for sale

This company is a leading provider of software solutions aimed at enhancing medication review processes. In particular, for older patients with multiple morbidities. Over the years, the company has grown to become a key player in the healthcare technology sector. In this case, with a focus on preventing adverse drug events (ADEs) and reducing hospital admissions.

Profile of software medication review solution provider in Europe for sale

Primarily, the company specializes in developing high-standard healthcare technologies, with a strong emphasis on evidence-based decision support for clinicians. Notably, their technologies are classified as Class 1 Medical Devices, harmonized with US standards, ensuring that their products meet rigorous safety and quality criteria. Essentially, the company collaborates closely with academic institutions, expert clinicians, and professional bodies.

Activity and services of software medication review solution provider in Europe for sale

Overall, the company’s core offering is a sophisticated medication review solution that provides evidence-based prescribing guidance. Chiefly, this solution is designed to review the appropriateness of medications for older patients with multiple chronic conditions and polypharmacy. Further, the technology leverages both the AGS Beers Criteria® and StoppStart® Criteria, making it the only company licensed to apply these critical standards. In addition, their exclusive commercial partnership with the American Geriatrics Society (AGS) enables them to deliver the first electronic version of the AGS Beers Criteria®. Specifically, the software analyzes patient history, demographics, medications, conditions, and lab results to make intelligent, patient-centered recommendations.

Highlights of software medication review solution provider in Europe for sale

• The company is distinguished by its focus on comprehensive medication review, analyzing both current and historical patient records to optimize prescriptions across the healthcare continuum.
• Their solutions are developed with over 90 prescribing rules validated by a panel of US experts and over 100 prescribing rules validated by a European panel, ensuring the highest standard of care.
• The company’s technology not only flags potential issues but also makes specific prescribing recommendations. Critically, it helps in identifying missing drug treatments and provides fast, reliable polypharmacy reviews.

More information on this software medication review solution provider in Europe for sale

Please get in touch if you are interested in learning more about this software medication review solution provider in Europe for sale. For more it other companies for sale please visit the section it other companies for sale. For other it other buyers, please visit the section it other companies wanted. If you are instead interested in companies for sale, please visit the companies for sale section. For buyers, please visit the section companies wanted.